CryoCath Technologies

CryoCath Technologies is a medical device company based in Montreal, Canada, focused on developing and commercializing catheter-based cryotherapy products for treating cardiac arrhythmias, particularly atrial fibrillation. The company is a leader in cryoablation technology, which utilizes extreme cold to destroy problematic cardiac tissue. The flagship product, the Arctic Front® cryoablation catheter, is a minimally invasive device designed to enhance the safety and ease of cardiac ablation procedures. It has been used in clinical trials and has treated approximately 3,100 patients globally. Additionally, CryoCath offers the FrostByte/SurgiFrost system, a convertible device that combines a clamp and surgical probe for interventional cardiologists, designed to improve procedural precision and reduce surgeon fatigue. Acquired by Medtronic in 2008, CryoCath continues to innovate in cryoablation technology, serving interventional cardiologists, electrophysiologists, hospitals, and cardiac treatment centers across North America and Europe.

• Employees 33